Results 171 to 180 of about 298,245 (212)
Some of the next articles are maybe not open access.
AN ELUTER FOR PAPER CHROMATOGRAMS
Canadian Journal of Biochemistry and Physiology, 1960Null
D. F. Sharman, M. Saffran
openaire +3 more sources
Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization
New England Journal of Medicine, 2005Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between the two types of drug-eluting stents.We conducted a randomized, controlled, single-blind trial comparing sirolimus-eluting stents with paclitaxel-eluting ...
Otto M. Hess +17 more
openaire +3 more sources
Future Cardiology, 2006
Percutaneous coronary intervention and stent implantation is rapidly becoming the most commonly used form of revascularization. The long term results of this procedure are limited by restenosis which is a phenomenon predominantly caused by proliferation of smooth muscle cells.
Simon Corbett +3 more
openaire +3 more sources
Percutaneous coronary intervention and stent implantation is rapidly becoming the most commonly used form of revascularization. The long term results of this procedure are limited by restenosis which is a phenomenon predominantly caused by proliferation of smooth muscle cells.
Simon Corbett +3 more
openaire +3 more sources
Annual Review of Medicine, 2004
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Andrew R. Marks, T Cooper Woods
openaire +6 more sources
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Andrew R. Marks, T Cooper Woods
openaire +6 more sources
Techniques in Vascular and Interventional Radiology, 2010
Ever since the first percutaneous transluminal angioplasty (PTA) was carried out in Switzerland in 1977, restenosis remains a major drawback of this minimally invasive treatment intervention. Numerous attempts to increase vessel patency after PTA have included systemic medications and endovascular brachytherapy, but these techniques have not met our ...
Dai-Do Do, Hanno Hoppe, Nicolas Diehm
openaire +2 more sources
Ever since the first percutaneous transluminal angioplasty (PTA) was carried out in Switzerland in 1977, restenosis remains a major drawback of this minimally invasive treatment intervention. Numerous attempts to increase vessel patency after PTA have included systemic medications and endovascular brachytherapy, but these techniques have not met our ...
Dai-Do Do, Hanno Hoppe, Nicolas Diehm
openaire +2 more sources
Catheterization and Cardiovascular Interventions, 2013
ObjectiveDrug‐eluting stent (DES) implantation is a very effective treatment of bare‐metal stent–in‐stent restenosis (BMS–ISR). Therapeutic options for drug‐eluting stent–in‐stent restenosis (DES–ISR) are less well defined, as there are only few data on safety and effectiveness of interventional modalities.
Nikolaus Marx +4 more
openaire +3 more sources
ObjectiveDrug‐eluting stent (DES) implantation is a very effective treatment of bare‐metal stent–in‐stent restenosis (BMS–ISR). Therapeutic options for drug‐eluting stent–in‐stent restenosis (DES–ISR) are less well defined, as there are only few data on safety and effectiveness of interventional modalities.
Nikolaus Marx +4 more
openaire +3 more sources
Principles of antibody elution
Transfusion, 1981Antibody‐antigen binding depends upon ionic, hydrophobic, and hydrogen bonds, as well as van der Waals forces and three‐dimensional conformation. Antibody elution techniques attempt to break those forces by alterations of ionic strength, pH, thermal agitation, and the use of organic solvents. Because of the heterogeneity of the physical forces involved
openaire +3 more sources
Long-term comparison of everolimus-eluting and biolimus-eluting stents
EuroIntervention, 2013Second-generation everolimus-eluting stents (EES) are safer and more efficient than first-generation paclitaxel-eluting stents (PES). Third-generation biolimus-eluting stents (BES) have been found to be non-inferior to PES. To date, there is no available comparative study between EES and BES.
Mario Togni +10 more
openaire +2 more sources
Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations
American Heart Journal, 2008The aim of the study was to compare the outcomes of sirolimus-eluting (SES) and paclitaxel-eluting (PES) stent implantation in coronary bifurcations treated with either a 1-stent or 2-stent strategy.The study used a retrospective cohort analysis of consecutive de novo bifurcations, excluding left main, treated with SES or PES between April 2003 and ...
Azeem Latib +12 more
openaire +3 more sources
Cardiovascular Revascularization Medicine, 2014
Patients requiring chronic hemodialysis (HD) are at high risk for restenosis after percutaneous coronary intervention (PCI) with bare metal stents. Outcome data on drug-eluting stent (DES) implantation in HD patients are limited and suggest superiority of paclitaxel-eluting stents (PES) over limus-eluting stents (LES).In total, 218 consecutive patients
Augusto D. Pichard +8 more
openaire +3 more sources
Patients requiring chronic hemodialysis (HD) are at high risk for restenosis after percutaneous coronary intervention (PCI) with bare metal stents. Outcome data on drug-eluting stent (DES) implantation in HD patients are limited and suggest superiority of paclitaxel-eluting stents (PES) over limus-eluting stents (LES).In total, 218 consecutive patients
Augusto D. Pichard +8 more
openaire +3 more sources